133 related articles for article (PubMed ID: 21212407)
1. The prostaglandin transporter regulates adipogenesis and aromatase transcription.
Subbaramaiah K; Hudis CA; Dannenberg AJ
Cancer Prev Res (Phila); 2011 Feb; 4(2):194-206. PubMed ID: 21212407
[TBL] [Abstract][Full Text] [Related]
2. Pioglitazone, a PPARγ agonist, suppresses CYP19 transcription: evidence for involvement of 15-hydroxyprostaglandin dehydrogenase and BRCA1.
Subbaramaiah K; Howe LR; Zhou XK; Yang P; Hudis CA; Kopelovich L; Dannenberg AJ
Cancer Prev Res (Phila); 2012 Oct; 5(10):1183-94. PubMed ID: 22787115
[TBL] [Abstract][Full Text] [Related]
3. EP2 and EP4 receptors regulate aromatase expression in human adipocytes and breast cancer cells. Evidence of a BRCA1 and p300 exchange.
Subbaramaiah K; Hudis C; Chang SH; Hla T; Dannenberg AJ
J Biol Chem; 2008 Feb; 283(6):3433-3444. PubMed ID: 18083712
[TBL] [Abstract][Full Text] [Related]
4. Increased levels of COX-2 and prostaglandin E2 contribute to elevated aromatase expression in inflamed breast tissue of obese women.
Subbaramaiah K; Morris PG; Zhou XK; Morrow M; Du B; Giri D; Kopelovich L; Hudis CA; Dannenberg AJ
Cancer Discov; 2012 Apr; 2(4):356-65. PubMed ID: 22576212
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin E(2) induces breast cancer related aromatase promoters via activation of p38 and c-Jun NH(2)-terminal kinase in adipose fibroblasts.
Chen D; Reierstad S; Lin Z; Lu M; Brooks C; Li N; Innes J; Bulun SE
Cancer Res; 2007 Sep; 67(18):8914-22. PubMed ID: 17875734
[TBL] [Abstract][Full Text] [Related]
6. Prostaglandin E2 induces interleukin-6 expression in human chondrocytes via cAMP/protein kinase A- and phosphatidylinositol 3-kinase-dependent NF-kappaB activation.
Wang P; Zhu F; Konstantopoulos K
Am J Physiol Cell Physiol; 2010 Jun; 298(6):C1445-56. PubMed ID: 20457835
[TBL] [Abstract][Full Text] [Related]
7. NFAT and CREB regulate Kaposi's sarcoma-associated herpesvirus-induced cyclooxygenase 2 (COX-2).
Sharma-Walia N; George Paul A; Patel K; Chandran K; Ahmad W; Chandran B
J Virol; 2010 Dec; 84(24):12733-53. PubMed ID: 20943963
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandin E2 activates cAMP response element-binding protein in glioma cells via a signaling pathway involving PKA-dependent inhibition of ERK.
Bidwell P; Joh K; Leaver HA; Rizzo MT
Prostaglandins Other Lipid Mediat; 2010 Feb; 91(1-2):18-29. PubMed ID: 20015475
[TBL] [Abstract][Full Text] [Related]
9. Involvement of transcription factor GATA-4 in regulation of CYP19 gene during folliculogenesis and luteinization in buffalo ovary.
Monga R; Ghai S; Datta TK; Singh D
J Steroid Biochem Mol Biol; 2012 May; 130(1-2):45-56. PubMed ID: 22245270
[TBL] [Abstract][Full Text] [Related]
10. CREB-regulated transcription co-activator family stimulates promoter II-driven aromatase expression in preadipocytes.
Samarajeewa NU; Docanto MM; Simpson ER; Brown KA
Horm Cancer; 2013 Aug; 4(4):233-41. PubMed ID: 23584792
[TBL] [Abstract][Full Text] [Related]
11. Aromatase expression in a human osteoblastic cell line increases in response to prostaglandin E(2) in a dexamethasone-dependent fashion.
Watanabe M; Noda M; Nakajin S
Steroids; 2007 Sep; 72(9-10):686-92. PubMed ID: 17614108
[TBL] [Abstract][Full Text] [Related]
12. cAMP/CREB-mediated transcriptional regulation of ectonucleoside triphosphate diphosphohydrolase 1 (CD39) expression.
Liao H; Hyman MC; Baek AE; Fukase K; Pinsky DJ
J Biol Chem; 2010 May; 285(19):14791-805. PubMed ID: 20178980
[TBL] [Abstract][Full Text] [Related]
13. Effect of epidermal growth factor and prostaglandin on the expression of aromatase (CYP19) in human adrenocortical carcinoma cell line NCI-H295R cells.
Watanabe M; Noda M; Nakajin S
J Endocrinol; 2006 Jan; 188(1):59-68. PubMed ID: 16394175
[TBL] [Abstract][Full Text] [Related]
14. CREB is required for cAMP/PKA signals upregulating neuropathy target esterase expression.
Chen JX; Wu YJ
DNA Cell Biol; 2013 Apr; 32(4):199-205. PubMed ID: 23517531
[TBL] [Abstract][Full Text] [Related]
15. The role of cyclooxygenase-2-dependent signaling via cyclic AMP response element activation on aromatase up-regulation by o,p'-DDT in human breast cancer cells.
Han EH; Kim HG; Hwang YP; Choi JH; Im JH; Park B; Yang JH; Jeong TC; Jeong HG
Toxicol Lett; 2010 Oct; 198(3):331-41. PubMed ID: 20678559
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of aromatase transcription via promoter II by short heterodimer partner in human preadipocytes.
Kovacic A; Speed CJ; Simpson ER; Clyne CD
Mol Endocrinol; 2004 Jan; 18(1):252-9. PubMed ID: 14593077
[TBL] [Abstract][Full Text] [Related]
17. CpG dinucleotide methylation of the CYP19 I.3/II promoter modulates cAMP-stimulated aromatase activity.
Demura M; Bulun SE
Mol Cell Endocrinol; 2008 Feb; 283(1-2):127-32. PubMed ID: 18201819
[TBL] [Abstract][Full Text] [Related]
18. cAMP/Protein Kinase A Signaling Inhibits Dlx5 Expression via Activation of CREB and Subsequent C/EBPβ Induction in 3T3-L1 Preadipocytes.
Lee HL; Qadir AS; Park HJ; Chung E; Lee YS; Woo KM; Ryoo HM; Kim HJ; Baek JH
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30322210
[TBL] [Abstract][Full Text] [Related]
19. JunD and JunB integrate prostaglandin E2 activation of breast cancer-associated proximal aromatase promoters.
Chen D; Reierstad S; Fang F; Bulun SE
Mol Endocrinol; 2011 May; 25(5):767-75. PubMed ID: 21393445
[TBL] [Abstract][Full Text] [Related]
20. Protein kinase A-dependent synergism between GATA factors and the nuclear receptor, liver receptor homolog-1, regulates human aromatase (CYP19) PII promoter activity in breast cancer cells.
Bouchard MF; Taniguchi H; Viger RS
Endocrinology; 2005 Nov; 146(11):4905-16. PubMed ID: 16109788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
